Claudio Thomaz Lobo Sonder

Claudio Thomaz Lobo Sonder currently works at Fundação Arymax, as Chief Executive Officer from 2018, RBS-Zero Hora Editora Jornalistica SA, as Director from 2001, EcoFuturo Institute, as Director from 2010, DSM Chemicals Rotterdam BV, as Director from 2001, Fundação Bienal de São Paulo, as Director, Hes Participaçoes SA, as Director from 2014, Alden Desenvolvimento Imobiliário Ltda, as Director from 2011, Associação Pinacoteca De Arte E Cultura, as Director, HBR Realty Empreendimentos Imobiliarios SA, as Independent Director from 2022, Sociedade Benef Israelitabras Hospital Albert Einstein, as Vice President-Deliberative Board, and Sonred Ltda., as Managing Partner from 2011.
Mr. Lobo Sonder also formerly worked at Hoechst Do Brasil Quimica E Farmaceutica SA, as Chairman & Chief Executive Officer from 1983 to 1993, Celanese AG, as Chairman-Management Board in 2004, Lojas Renner SA, as Chairman from 2008 to 2013, Suzano Holding SA, as Vice Chairman, Suzano SA, as Vice Chairman, IPLF Holding SA, as Chairman, MDS, SGPS SA, as Chairman from 2018 to 2021, Polpar SA, as Vice Chairman, Braskem Petroquimica Ltda., as Director, RBS Participações SA, as Director, Companhia Suzano de Papel é Celulose SA, as Director from 2001 to 2005, Óleo e Gás Participações SA, as Director in 2010, Cyrela Brazil Realty SA Empreendimentos e Participações, as Director from 2010 to 2011, Hospital Albert Einstein, as Director-Deliberative Council, Rbs SA, as Director, Hoechst AG, as Member-Management Board, DSM BV, as Independent Member-Supervisory Board from 2011 to 2013, Sociedade de Cultura Artistica, as Council President, and OGX SA, as Member-Management Board.
Mr. Lobo Sonder received his undergraduate degree from Universidade Presbiteriana Mackenzie and graduate degree in 1973 from Harvard Business School.